Securian Asset Management Inc. Sells 736 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Securian Asset Management Inc. lessened its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 4.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 15,027 shares of the medical instruments supplier’s stock after selling 736 shares during the period. Securian Asset Management Inc.’s holdings in DENTSPLY SIRONA were worth $285,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Riverview Trust Co bought a new position in DENTSPLY SIRONA during the 4th quarter worth $26,000. MassMutual Private Wealth & Trust FSB increased its stake in DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock worth $27,000 after acquiring an additional 1,232 shares during the period. UMB Bank n.a. increased its stake in DENTSPLY SIRONA by 60.8% during the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after acquiring an additional 564 shares during the period. Brooklyn Investment Group bought a new position in DENTSPLY SIRONA during the 3rd quarter worth $77,000. Finally, Quarry LP increased its stake in DENTSPLY SIRONA by 455.0% during the 3rd quarter. Quarry LP now owns 3,036 shares of the medical instruments supplier’s stock worth $82,000 after acquiring an additional 2,489 shares during the period. Institutional investors own 95.70% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on XRAY shares. Wells Fargo & Company decreased their price target on DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating on the stock in a research note on Friday, February 28th. StockNews.com lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Barrington Research decreased their price target on DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a research note on Friday, February 28th. UBS Group decreased their price target on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a research note on Tuesday, December 3rd. Finally, Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Twelve analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $23.33.

Get Our Latest Research Report on DENTSPLY SIRONA

Insiders Place Their Bets

In related news, Director Gregory T. Lucier bought 15,142 shares of the business’s stock in a transaction on Monday, March 3rd. The shares were purchased at an average cost of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now owns 81,971 shares of the company’s stock, valued at $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Stock Up 1.0 %

Shares of XRAY opened at $15.74 on Wednesday. The company has a market capitalization of $3.13 billion, a PE ratio of -7.60, a PEG ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA Inc. has a 12 month low of $14.78 and a 12 month high of $33.72. The stock’s 50-day moving average price is $18.10 and its two-hundred day moving average price is $20.67. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 4.07%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA’s payout ratio is presently -14.07%.

DENTSPLY SIRONA Company Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Articles

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.